News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Stephen V Liu: Beautiful Review on Neoadjuvant Immunotherapy Across Tumor Types
Stephen V Liu/X
Jun 25, 2025, 23:31

Stephen V Liu: Beautiful Review on Neoadjuvant Immunotherapy Across Tumor Types

Stephen V Liu, Director of Thoracic Oncology and Associate Professor of Medicine at Georgetown University, shared a post on X:

“Beautiful review on neoadjuvant immunotherapy across tumor types and how we can further refine delivery and develop biomarkers, Nature Cancer.
Congratulations to Drs. Gil Awada, Tina Cascone, Michiel van der Heijden, Christian Blank, Marleen Kok, Myriam Chalabi.”

Title: The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types

Journal: Nature Cancer

Authors: Gil Awada, Tina Cascone, Michiel S. van der Heijden, Christian U. Blank, Marleen Kok, Myriam Chalabi

Read the full article.

Stephen V Liu: Beautiful Review on Neoadjuvant Immunotherapy Across Tumor Types

More posts featuring Stephen V Liu on OncoDaily.

cancer Christian Blank Christian U. Blank Georgetown University Gil Awada Marleen Kok Michiel S. Van der Heijden Michiel van der Heijden Myriam Chalabi OncoDaily Oncology Stephen V Liu Tina Cascone
Special Coverage
Insight
Jun 25, 2025, 23:31
Stephen V Liu: Beautiful Review on Neoadjuvant Immunotherapy Across Tumor Types
Insight
Jun 25, 2025, 23:20
Nicolas Hart: Our New Paper, Led by Takemura Naomi - Introducing the ‘Treatable Traits’ Paradigm to Cancer Care
Insight
Jun 25, 2025, 23:03
Cristiane D Bergerot: How Does Cancer-related Distress Differ Between Brazil and Mexico?
Blog
Jun 25, 2025, 22:49
Darcy Burbage: On My Way to Seattle for MASCC25
Opinion
Jun 25, 2025, 22:05
Supriya Peshin Shared Details on The 2025 Portland Cholangiocarcinoma Symposium
Blog
Jun 25, 2025, 21:21
Galip Can Uyar: Ovarian Cancer Treatment Is Entering a New Era
Blog
Jun 25, 2025, 21:00
Pillar 3 of the National Cancer Control Strategy, 2023-2027: Cancer Treatment, Palliative Care and Survivorship - NCI Kenya
Insight
Jun 25, 2025, 20:47
Saadvik Raghuram Y: FDA Approves Talectrectinib for ROS1-Positive Locally Advanced or Metastatic NSCLC
Career
Jun 25, 2025, 20:30
NFCR Awarded 2025 Szent-Györgyi Prize to Anthony R. Hunter for Progress in Cancer Research
Insight
Jun 25, 2025, 17:58
Shankar Siva: We Randomised the Final Patient on TROG Cancer Research 19.06 DECREASE Trial
Blog
Jun 25, 2025, 17:39
Julie Gralow: Pleased to Participate in This Well-organized Best of ASCO UAE Program in Abu Dhabi
Science
Jun 25, 2025, 16:50
Cedric Blanpain Shares New Study on the Role of Innate Immunity in Regulating Cell Plasticity and Reprogramming of Prostate Tumor Initiating Cells